Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Taenia solium antigens are a diverse set of molecules, including proteins and glycoproteins, expressed by the pork tapeworm during its various life stages. These antigens play a pivotal role in the pathogenesis of cysticercosis and neurocysticercosis by mediating host-parasite interactions and facilitating the parasite's evasion of the host immune system (Garcia et al., 2014). In clinical diagnostics, specific antigens such as the HP10 secretory antigen and low-molecular-weight glycoproteins are targeted in enzyme-linked immunosorbent assays (ELISA) to identify active infections (Handali et al., 2010). While standard anthelmintic treatments like albendazole and praziquantel do not bind these antigens directly, they cause the death of the larvae, which results in a massive release of antigenic material into the host tissue (Nash et al., 2011). This sudden exposure often triggers a severe inflammatory response, particularly in the brain, leading to complications such as cerebral edema and seizures, which typically require management with corticosteroids (White, 2014). Furthermore, specific antigens like TSOL18 have been successfully utilized in the development of highly effective veterinary vaccines to break the transmission cycle of the parasite (Lightowlers, 2010).
Anthelmintic agents like albendazole and praziquantel induce parasite death, which triggers the release of Taenia solium antigens into the host environment; corticosteroids such as dexamethasone are subsequently used to mitigate the inflammatory response elicited by these released antigens.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taenia solium antigen (Ts Ag).